Hippo signaling plays an essential role in cell state transitions during cardiac fibroblast development Y Xiao, MC Hill, M Zhang, TJ Martin, Y Morikawa, S Wang, AR Moise, ... Developmental cell 45 (2), 153-169. e6, 2018 | 169 | 2018 |
Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia by Inhibition of Ca2+/Calmodulin-Dependent Kinase II VJ Bezzerides, A Caballero, S Wang, Y Ai, RJ Hylind, F Lu, ... Circulation 140 (5), 2019 | 105 | 2019 |
AAV gene therapy prevents and reverses heart failure in a murine knockout model of Barth syndrome S Wang, Y Li, Y Xu, Q Ma, Z Lin, M Schlame, VJ Bezzerides, D Strathdee, ... Circulation research 126 (8), 1024-1039, 2020 | 79 | 2020 |
Increased Reactive Oxygen Species–Mediated Ca2+/Calmodulin-Dependent Protein Kinase II Activation Contributes to Calcium Handling Abnormalities and … X Liu, S Wang, X Guo, Y Li, R Ogurlu, F Lu, M Prondzynski, ... Circulation 143 (19), 1894-1911, 2021 | 57 | 2021 |
Retinol saturase modulates lipid metabolism and the production of reactive oxygen species XY Pang, S Wang, MJ Jurczak, GI Shulman, AR Moise Archives of biochemistry and biophysics 633, 93-102, 2017 | 51 | 2017 |
Alterations in retinoic acid signaling affect the development of the mouse coronary vasculature S Wang, W Huang, HA Castillo, MA Kane, J Xavier‐Neto, PA Trainor, ... Developmental Dynamics 247 (8), 976-991, 2018 | 37 | 2018 |
Retinoic acid signaling promotes the cytoskeletal rearrangement of embryonic epicardial cells S Wang, J Yu, JW Jones, K Pierzchalski, MA Kane, PA Trainor, ... The FASEB Journal 32 (7), 3765, 2018 | 35 | 2018 |
Modulation of retinoid signaling: therapeutic opportunities in organ fibrosis and repair S Wang, J Yu, MA Kane, AR Moise Pharmacology & therapeutics 205, 107415, 2020 | 30 | 2020 |
Current and future treatment approaches for Barth syndrome R Thompson, J Jefferies, S Wang, WT Pu, C Takemoto, B Hornby, ... Journal of Inherited Metabolic Disease 45 (1), 17-28, 2022 | 19 | 2022 |
Recent Insights on the Role and Regulation of Retinoic Acid Signaling during Epicardial Development S Wang, AR Moise Genesis 57 (7-8), 2019 | 14 | 2019 |
Genetic modifiers modulate phenotypic expression of tafazzin deficiency in a mouse model of Barth syndrome S Wang, E Yazawa, EM Keating, N Mazumdar, A Hauschild, Q Ma, H Wu, ... Human Molecular Genetics 32 (12), 2055-2067, 2023 | 13 | 2023 |
A new murine model of Barth syndrome neutropenia links TAFAZZIN deficiency to increased ER stress-induced apoptosis J Sohn, J Milosevic, T Brouse, N Aziz, J Elkhoury, S Wang, A Hauschild, ... Blood advances 6 (8), 2557-2577, 2022 | 13 | 2022 |
AAV gene transfer to the heart S Wang, Y Guo, WT Pu Cardiac Regeneration: Methods and Protocols, 269-280, 2021 | 10 | 2021 |
Calcific aortic valve disease: turning therapeutic discovery up a notch S Wang, WT Pu Nature Reviews Cardiology 18 (5), 309-310, 2021 | 2 | 2021 |
Taz gene or enzyme replacement therapy WT Pu, S Wang US Patent App. 17/799,418, 2023 | | 2023 |
Optimizing AAV Gene Therapy Strategies for Barth Syndrome S Wang, Y Li, W Pu MOLECULAR THERAPY 27 (4), 51-52, 2019 | | 2019 |
SUPPLMENTAL MATERIAL VJ Bezzerides, A Caballero, S Wang, Y Ai, BS Chambers, D Zhang, ... | | |